Benzinga | Aug 17, 2021 08:12AM EDT

Cyclo Therapeutics Monday Reported Q2 EPS $(0.56) Beats $(0.76) Estimate, Sales $238.59K Miss $358.00K Estimate

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.76) by 26.32 percent. The company reported quarterly sales of $238.59 thousand which missed the analyst consensus estimate of $358.00 thousand by 33.35 percent.